Regencell Bioscience Cash Flow Statement
NASDAQ: RGCHealth Care Medicinal Chemicals and Botanical Products USD
7.35-0.28 (-3.67%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Regencell Bioscience free cash flow
In fiscal 2026, Regencell Bioscience generated -$7.7 million of operating cash flow. That left free cash flow of -$7.7 million.
Summary generated from market data by MetaCap's automated system. Methodology
Regencell Bioscience cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-06-30 | FY 20252025-06-30 | FY 20242024-06-30 | FY 20232023-06-30 | FY 20222022-06-30 | FY 20212021-06-30 | FY 20202020-06-30 | FY 20192019-06-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -11.70M | -3.58M | -4.36M | -6.06M | -7.59M | -1.35M | -812.37K | -390.99K |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 80.91K | 77.69K | 305.78K | 293.13K | 150.15K | 26.46K | 9.52K | — |
| Stock-Based Compensation | 3.23M | 244.81K | 449.31K | 922.62K | 2.76M | 922.62K | — | — |
| Change in Working Capital | — | — | — | — | — | 477.99K | 95.00K | — |
| Operating Cash Flow | -7.70M | -3.11M | -4.00M | -4.96M | -5.27M | -767.31K | -726.57K | -390.99K |
| Capital Expenditures | — | -152.69K | -5.38K | -27.39K | -780.88K | — | -117.84K | — |
| Investing Cash Flow | 2.50M | 2.69M | 5.24M | 58.98K | -10.78M | — | -117.84K | — |
| Debt Issued | — | — | — | — | 301.08K | — | — | — |
| Financing Cash Flow | 16.95M | — | 102.28K | 134.91K | 22.41M | 439.75K | 988.08K | 480.99K |
| Net Change in Cash | 11.77M | -542.12K | 1.40M | -4.85M | 6.36M | -327.57K | 143.67K | 90.00K |
| Free Cash Flow | -7.70M | -3.27M | -4.01M | -4.99M | -6.05M | -767.31K | -844.41K | -390.99K |
This table shows 8 annual periods of Regencell Bioscience's cash flow statement, from FY 2026 back to FY 2019, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RGC's reporting calendar. What is a cash flow statement?